Q3 2019 Holdings
Filed 2019-11-14 | 49 holdings | $170.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $113.3M | 925,000 | 66.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $30.3M | 450,000 | 17.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $22.8M | 200,000 | 13.4% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $2.7M | 300,000 | 1.6% |
| Spark Therapeutics Inc | COM | 84652J103 | $160.0K | 1,650,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $133.7K | 1,715,560 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $92.2K | 6,950,000 | 0.1% |
| Odonate Therapeutics Inc | COM | 676079106 | $87.5K | 3,363,377 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $53.1K | 675,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $53.1K | 3,500,000 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $45.6K | 5,300,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $45.0K | 2,075,905 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $41.4K | 550,000 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $40.3K | 3,896,872 | 0.0% |
| Medicines Co | COM | 584688105 | $37.5K | 750,000 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $35.7K | 975,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $34.8K | 2,075,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $34.1K | 865,400 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $33.8K | 1,000,000 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $21.2K | 1,733,583 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $20.6K | 1,102,194 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $20.5K | 1,000,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $18.6K | 2,325,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $17.1K | 1,466,051 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $16.9K | 700,000 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $13.8K | 1,123,105 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $12.8K | 844,789 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $12.1K | 250,000 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $12.0K | 300,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $11.3K | 1,775,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $11.0K | 482,495 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $10.1K | 4,000,000 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $8.6K | 500,000 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $8.5K | 600,000 | 0.0% |
| Immunomedics IncCall | CALL | 452907908 | $8.0K | 600,000 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $7.5K | 2,500,000 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $7.2K | 2,000,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $6.9K | 764,252 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $6.8K | 775,000 | 0.0% |
| Matinas Biopharma Hldgs Inc | COM | 576810105 | $6.4K | 10,188,312 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $6.4K | 1,250,000 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $4.9K | 2,913,091 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.0K | 400,000 | 0.0% |
| Mersana Therapeutics Inc. | COM | 59045L106 | $2.7K | 1,680,800 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $2.5K | 290,577 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.3K | 200,000 | 0.0% |
| Cellectar Biosciences Inc | COM PAR | 15117F500 | $1.8K | 920,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $624 | 79,598 | 0.0% |
| Novus Therapeutics Inc | COM | 67011N105 | $201 | 324,383 | 0.0% |